Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

STATUS

Recruiting
participants needed

129
sponsor

Fujian Cancer Hospital

Send

Updated on 19 February 2024

See if I qualify

nasopharyngeal carcinoma

chemoradiotherapy

carcinoma

capecitabine

alt/ast

nasopharyngeal biopsy

Summary

This study is a randomized, phase II, prospective, multicenter clinical trial to evaluate the efficacy and safety of radical chemoradiotherapy plus oral capecitabine/teggio for 1 year in patients with N3.

Details

Condition	Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Cancer
Age	18-65 years
Treatment	Capecitabine/Tiggio
Clinical Study Identifier	NCT04220528
Sponsor	Fujian Cancer Hospital
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Pathologic diagnosis (pathologically confirmed by nasopharyngeal biopsy) was nasopharyngeal carcinoma
	No distant metastatic stage N3 nasopharyngeal carcinoma was first diagnosed (according to the 8th edition UICC/AJCC nasopharyngeal carcinoma staging system defined as any T and N3M0 stage nasopharyngeal carcinoma)
	Aged 18-65
	At least one measurable tumor lesion
	PS (ECOG standard) 0-1
	Adequate hematopoietic function: WBC3.5109/L, Hb100g/L, PLT100109/L
	Normal liver and kidney functions: ALT/AST < 2.5 times the upper limit of normal value (ULN), total bilirubin < 1.5ULN;Serum creatinine < 1.5ULN
	Expected survival period 6 months
	Signing informed consent
	Follow up regularly and comply with test requirements
Exclusion Criteria
	Patients with distant organ metastasis
	Recurrent nasopharyngeal carcinoma
	Creatinine clearance rate <60ml/ min
	Have received chemotherapy, radiotherapy or targeted therapy
	Have or are suffering from other malignant tumors within 5 years (except non-melanoma skin cancer or pre-invasive cervical cancer)
	Serious complications, such as uncontrolled hypertension, coronary heart disease, diabetes, heart failure, etc
	Active systemic infection
	History of serious lung or heart disease
	Drug or alcohol abuse
	No or limited capacity for civil conduct
	The patient has a physical or mental disorder, and the researcher considers that the patient is unable to fully or fully understand the possible complications of this study
	Receive chronic systemic immunotherapy or hormone therapy outside the study
	Pregnancy or lactation period
	Patients receive blind treatment in other clinical studies

How to participate?

Step 1 Connect with a study center

Select a site
Send a message

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Primary Contact

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

nasopharyngeal carcinoma

nasopharyngeal biopsy

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Study Definition

Wikipedia

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC